医薬品添加剤市場 – 2030年までの世界予測

この調査レポートでは、医薬品添加剤市場を製品別（有機（油脂化学品、炭水化物、石油化学品、タンパク質、その他の有機化学品）、無機（リン酸カルシウム、金属酸化物、岩塩、炭酸カルシウム、硫酸カルシウム、その他の無機化学品）、その他の化学品）、機能性別（充填剤および希釈剤、懸濁剤および粘稠剤、コーティング剤、結合剤、香料および甘味料、崩壊剤、着色料、滑沢剤および流動促進剤、防腐剤、乳化剤、その他の機能性）、処方別（経口（錠剤、カプセル、液状製剤およびその他の経口製剤）、局所製剤、非経口製剤およびその他の製剤）、機能性用途別（安定剤、風味付与、放出制御、溶解性およびバイオアベイラビリティ向上）に分類しています。 （およびその他の機能アプリケーション）、および地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分析します。
本レポートは、医薬品添加剤市場の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、製品、ソリューション、主要戦略、提携、パートナーシップ、契約に関する洞察を提供しています。医薬品添加剤市場に関連する新規承認／発売、提携、買収、最近の動向についても取り上げています。

The global pharmaceutical excipients market is projected to reach USD 14.86 billion by 2030 from USD 11.03 billion in 2025, at a CAGR of 6.1% during the forecast period. The expansion of the Pharmaceutical Excipients market has been predominantly driven by the Surging demand for pharmaceutical products and generic medicines, and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market.

世界の医薬品添加剤市場は、2025年の110億3,000万米ドルから2030年には148億6,000万米ドルに達し、予測期間中は年平均成長率（CAGR）6.1%で成長すると予測されています。医薬品添加剤市場の拡大は、主に医薬品およびジェネリック医薬品の需要の急増によって牽引されており、今後数年間は新規添加剤開発への研究開発投資が市場を押し上げると予測されています。さらに、製薬企業との提携や協業、そして患者中心の処方への注力の高まりが、市場の成長機会の拡大につながると予想されます。しかしながら、規制の厳格化と開発コストの高騰が市場の成長を阻害すると予測されています。

The fillers & diluents functionality held the highest share in the pharmaceutical excipients market.

The pharmaceutical excipients market, segmented by functionality, includes binders, suspending and viscosity agents, fillers and diluents, flavoring agents and sweeteners, colorants, coating agents, lubricants and glidants, preservatives, disintegrants, emulsifying agents, and other specialized roles. Among these, fillers and diluents play a critical role, especially in the production of solid oral dosage forms like tablets and capsules. Their importance continues to grow with the rising demand for oral medications, which remain the most preferred route due to ease of administration and patient compliance. Fillers and diluents provide bulk to formulations containing small amounts of active pharmaceutical ingredients and help ensure accurate dosage and improved content uniformity. From a manufacturing perspective, they contribute significantly to formulation stability, ease of processing, and scalability in mass production. They simplify processes such as blending, tableting, and encapsulation while enhancing the mechanical strength of tablets. For patients, these excipients improve mouthfeel, taste, and handling, which are crucial factors for pediatric and geriatric populations. As drug formulations become more complex, the demand for high-performance, multifunctional fillers and diluents that support controlled release and bioavailability enhancement is also rising, presenting significant growth opportunities in this excipient category.

The oral formulations segment reported the highest share of the formulations segment in 2024.

The pharmaceutical excipients market is categorized based on formulation types into oral formulations, topical formulations, parenteral formulations, and other formulations. Among these, the oral formulations segment held the largest market share in 2024, reflecting its dominance as the most widely used and traditional drug delivery method. The convenience, cost-effectiveness, and high patient compliance associated with oral administration make it a preferred choice for patients and healthcare providers. This segment continues to expand due to the rising demand for tablets, capsules, and other solid oral dosage forms. Furthermore, the rapid growth of the biopharmaceutical and generics industries is playing a pivotal role in driving demand for high-quality excipients that enhance drug stability, solubility, and bioavailability in oral products. The increasing prevalence of chronic conditions requiring long-term medication and the trend toward self-administration of drugs also contribute to the growth of this segment. As a result, pharmaceutical companies are investing in innovative oral drug formulations, boosting the need for advanced excipients tailored to these needs.

Asia Pacific is expected to grow at the highest CAGR in the global pharmaceutical excipients market from 2025 to 2030.

The pharmaceutical excipients market in the Asia Pacific region is expected to grow robustly and register the highest CAGR among all regions during the forecast period. Several interrelated factors are driving this expansion. One of the key advantages is the region’s cost-effective manufacturing capabilities, which make it an attractive hub for pharmaceutical production and outsourcing. Countries like India, China, and South Korea offer abundant raw material availability, skilled labor, and favorable government policies that support pharmaceutical R&D and export-oriented manufacturing. Additionally, the Asia Pacific region has relatively lenient regulatory frameworks compared to Western markets, which accelerates product development and time-to-market. The rapid rise in per capita income, growing awareness of health and wellness, and increased healthcare spending are further fueling demand for generic drugs and, by extension, pharmaceutical excipients. Moreover, a surge in lifestyle-related chronic diseases and expanding geriatric populations have led to greater demand for innovative drug formulations, including oral solids and topical applications. These trends create significant opportunities for local and global excipient manufacturers to expand operations, invest in infrastructure, and form strategic partnerships to meet the growing regional demand.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side-70% and Demand Side-30%
• By Designation: Managers-45%, CXOs and Directors-30%, and Executives-25%
• By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5%

List of Key Companies Profiled in the Report

Key players in the pharmaceutical excipients  market include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Frères (France), MERCK KGaA (Germany),  Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc(UK), Chemie Trade(India), Gattefossé (France), JRS Pharma(US),  and Shin-Etsu Chemical Co., Ltd. (Japan).

Research Coverage

This research report categorizes the pharmaceutical excipients market by Product [(Organic (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, and Other Organic Chemicals), Inorganic (Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulfate, Other Inorganic Chemicals), Other chemicals], by Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, and Other Functionalities), by formulation (Oral (Tablets, Capsules, Liquid Formulations and other oral formulations), Topical Formulations, Parenteral Formulations, and Other Formulations), by Functionality Application (Stabilizers, Taste Making, Modified Release, Solubility & Bioavailability Enhancement and Other Functionality Applications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical excipients market.

Reasons to Buy this Report

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Surging demand for generic medications and pharmaceutical formulations, Increased R&D investments to develop novel excipients, A growing focus on patient-centric drug formulations, Strategic collaborations and partnerships with pharmaceutical firms), restraints (Strict and complex regulatory frameworks, High costs associated with excipient development and manufacturing), opportunities (Increasing interest in functional and multifunctional excipients, Technological advancements, particularly in nanotechnology, Expansion into emerging economies across Asia Pacific and Latin America), and Challenges (Ongoing concerns about excipient safety and quality standards, Limited availability and fluctuating costs of key raw materials).
• Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the Pharmaceutical Excipients market.
• Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical excipients market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical excipients market.

Table of Contents

1               INTRODUCTION              61

1.1           STUDY OBJECTIVES       61

1.2           MARKET DEFINITION   61

1.3           STUDY SCOPE   61

1.3.1        MARKET SEGMENTATION           62

1.3.2        REGIONAL SCOPE            63

1.3.3        INCLUSIONS AND EXCLUSIONS 63

1.3.4        YEARS CONSIDERED      64

1.4           CURRENCY CONSIDERED            64

1.5           STAKEHOLDERS               64

1.6           SUMMARY OF CHANGES               65

2               RESEARCH METHODOLOGY       66

2.1           RESEARCH DATA              66

2.1.1        SECONDARY DATA          67

2.1.1.1    Objectives of secondary research       67

2.1.1.2    Key data from secondary sources       68

2.1.2        PRIMARY DATA 68

2.1.2.1    Breakdown of primary interviews      69

2.1.2.2    Key objectives of primary research    69

2.2           MARKET ESTIMATION  70

2.2.1        GLOBAL MARKET ESTIMATION 70

2.2.1.1    Company revenue analysis (Bottom-up approach)         70

2.2.1.2    Revenue share analysis        71

2.2.1.3    MnM repository analysis     72

2.2.1.4    Primary interviews                72

2.2.2        INSIGHTS FROM PRIMARY EXPERTS        73

2.2.3        SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)       73

2.3           GROWTH RATE PROJECTIONS  75

2.4           DATA TRIANGULATION                77

2.5           RESEARCH ASSUMPTIONS           78

2.6           RESEARCH LIMITATIONS             78

2.7           RISK ANALYSIS  79

3               EXECUTIVE SUMMARY  80

4               PREMIUM INSIGHTS       84

4.1           PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW                 84

4.2           NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET               85

4.3           PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES            86

4.4           PHARMACEUTICAL EXCIPIENTS MARKET: EMERGING VS. DEVELOPED MARKETS,

2025 VS. 2030 (USD MILLION)      86

5               MARKET OVERVIEW       87

5.1           INTRODUCTION              87

5.2           MARKET DYNAMICS       87

5.2.1        DRIVERS               88

5.2.1.1    Surging demand for generic medications and pharmaceutical formulations.         88

5.2.1.2    Increased R&D investments to develop novel excipients                 90

5.2.1.3    Growing focus on patient-centric drug formulations     91

5.2.1.4    Strategic collaborations and partnerships among pharmaceutical firms       91

5.2.2        RESTRAINTS      92

5.2.2.1    Strict and complex regulatory frameworks       92

5.2.2.2    High cost of excipient development and manufacturing                 93

5.2.3        OPPORTUNITIES              94

5.2.3.1    Increasing interest in functional and multifunctional excipients                 94

5.2.3.2    Technological advancements in nanotechnology             95

5.2.3.3    Market opportunities in emerging economies 96

5.2.4        CHALLENGES    97

5.2.4.1    Ongoing concerns about excipient safety and quality standards                 97

5.2.4.2    Limited availability and fluctuating costs of key raw materials                 97

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            98

5.4           PRICING ANALYSIS          99

5.4.1        INDICATIVE PRICING ANALYSIS, BY KEY PLAYER                 99

5.4.2        INDICATIVE PRICING ANALYSIS, BY REGION      100

5.5           VALUE CHAIN ANALYSIS               101

5.6           SUPPLY CHAIN ANALYSIS             103

5.7           ECOSYSTEM ANALYSIS  104

5.8           INVESTMENT AND FUNDING SCENARIO               106

5.9           TECHNOLOGY ANALYSIS             107

5.9.1        KEY TECHNOLOGIES     107

5.9.1.1    Co-processed excipient technology   107

5.9.1.2    Nanotechnology-based excipients     107

5.9.2        COMPLEMENTARY TECHNOLOGIES       107

5.9.2.1    3D printing/additive manufacturing 107

5.9.2.2    Process Analytical Technology (PAT)              107

5.9.3        ADJACENT TECHNOLOGIES       107

5.9.3.1    Artificial intelligence in formulation design     107

5.9.3.2    Green chemistry/sustainability tech 107

5.10         PATENT ANALYSIS          108

5.11         TRADE ANALYSIS             109

5.11.1      TRADE DATA FOR HS CODE 290545          110

5.11.1.1  Import data for HS code 290545        110

5.11.1.2  Export data for HS code 290545         111

5.11.2      TRADE DATA FOR HS CODE 350510          112

5.11.2.1  Import data for HS code 350510        112

5.11.2.2  Export data for HS code 350510         113

5.11.3      TRADE DATA FOR HS CODE 290532          114

5.11.3.1  Import data for HS code 290532        114

5.11.3.2  Export data for HS code 290532         115

5.11.4      TRADE DATA FOR HS CODE 283650          116

5.11.4.1  Import data for HS code 283650        116

5.11.4.2  Export data for HS code 283650         117

5.11.5      TRADE DATA FOR HS CODE 250100          118

5.11.5.1  Import data for HS code 250100        118

5.11.5.2  Export data for HS code 250100         119

5.11.6      TRADE DATA FOR HS CODE 290543          120

5.11.6.1  Import data for HS code 290543        120

5.11.6.2  Export data for HS code 290543         121

5.11.7      TRADE DATA FOR HS CODE 3912              122

5.11.7.1  Import data for HS code 3912             122

5.11.7.2  Export data for HS code 3912             123

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        124

5.13         REGULATORY LANDSCAPE         125

5.13.1      REGULATORY FRAMEWORK       125

5.13.1.1  US           125

5.13.1.2  Europe   126

5.13.1.3  China      126

5.13.1.4  India       127

5.13.1.5  Brazil      127

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             128

5.14         PORTER’S FIVE FORCES ANALYSIS           130

5.14.1      BARGAINING POWER OF SUPPLIERS       131

5.14.2      BARGAINING POWER OF BUYERS             131

5.14.3      THREAT OF NEW ENTRANTS      131

5.14.4      THREAT OF SUBSTITUTES          132

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 132

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     132

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           132

5.15.2      KEY BUYING CRITERIA  133

5.16         IMPACT OF AI/GEN AI ON PHARMACEUTICAL EXCIPIENTS MARKET     134

5.16.1      INTRODUCTION              134

5.16.2      MARKET POTENTIAL OF AI ON PHARMACEUTICAL EXCIPIENTS       135

5.16.3      AI USE CASES     135

5.16.4      KEY COMPANIES IMPLEMENTING AI      137

5.16.5      FUTURE OF GENERATIVE AI IN PHARMACEUTICAL EXCIPIENT ECOSYSTEM                137

5.17         IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL EXCIPIENTS MARKET     138

5.17.1      INTRODUCTION              138

5.17.2      KEY TARIFF RATES          138

5.17.3      PRICE IMPACT ANALYSIS             139

5.17.4      IMPACT ON COUNTRY/REGION                140

5.17.4.1  North America      140

5.17.4.1.1                US           140

5.17.4.2  Europe   140

5.17.4.3  Asia Pacific            140

5.17.5      IMPACT ON END-USE INDUSTRIES          140

6               PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT                 142

6.1           INTRODUCTION              143

6.2           ORGANIC CHEMICALS   143

6.2.1        OLEOCHEMICALS            146

6.2.1.1    Fatty alcohols        149

6.2.1.1.1 Need for improved drug absorption to augment growth                 149

6.2.1.2    Mineral stearates  151

6.2.1.2.1 Wide use of magnesium stearates as excipients in nutraceutical and pharmaceutical formulations to drive market           151

6.2.1.3    Glycerin 154

6.2.1.3.1 Non-toxic, colorless, and odorless properties to encourage growth                 154

6.2.1.4    Other oleochemicals            156

6.2.2        CARBOHYDRATES           158

6.2.2.1    Sugars    161

6.2.2.1.1 Actual sugars         164

6.2.2.1.1.1              Growing use of actual sugars in pediatric formulations to propel market   164

6.2.2.1.1.2              Lactose   167

6.2.2.1.1.3              Sucrose  169

6.2.2.1.1.4              Dextrose (D-Glucose)         172

6.2.2.1.2 Sugar alcohols       174

6.2.2.1.2.1              Surging trend in consumer demand for healthier alternatives to conventional sweeteners to fuel market  174

6.2.2.1.2.2              Sorbitol  177

6.2.2.1.2.3              Mannitol                 179

6.2.2.1.2.4              Other sugar alcohols            182

6.2.2.1.3 Artificial sweeteners             184

6.2.2.1.3.1              Increasing use of sugar substitutes to favor growth                 184

6.2.2.2    Cellulose                 187

6.2.2.2.1 Microcrystalline cellulose    190

6.2.2.2.1.1              Versatility, safety, and cost-effectiveness to facilitate growth    190

6.2.2.2.2 Cellulose ethers    192

6.2.2.2.2.1              Higher effectiveness than other water-soluble polymers to fuel market        192

6.2.2.2.3 CMC & croscarmellose sodium          195

6.2.2.2.3.1              Growing trend of sourcing CMC from more viable alternatives to boost market                195

6.2.2.2.4 Cellulose esters     198

6.2.2.2.4.1              Increasing focus on targeted and sustained-release drug delivery systems to sustain growth     198

6.2.2.3    Starch     200

6.2.2.3.1 Modified starch    203

6.2.2.3.1.1              Cold-water swelling and gel barrier formation capabilities to fuel market   203

6.2.2.3.2 Dried starch           205

6.2.2.3.2.1              Strong binding and coating properties to augment growth    205

6.2.2.3.3 Converted starch  208

6.2.2.3.3.1              Enhanced solubility and stability for drugs to foster growth    208

6.2.3        PETROCHEMICALS          210

6.2.3.1    Glycols   213

6.2.3.1.1 Polyethylene glycol               216

6.2.3.1.1.1              Solubility, lubricity, and compatibility with APIs to drive market    216

6.2.3.1.2 Propylene glycol   218

6.2.3.1.2.1              Rising use of propylene glycol in oral and injectable formulations to foster growth             218

6.2.3.2    Povidones               220

6.2.3.2.1 Increasing demand for fast-dissolving tablets to spur growth                 220

6.2.3.3    Mineral hydrocarbons          223

6.2.3.3.1 Petrolatum             226

6.2.3.3.1.1              Strong presence in topical pharmaceutical formulations to expedite growth                226

6.2.3.3.2 Mineral waxes       228

6.2.3.3.2.1              Utilization of mineral waxes in solid and semi-solid dosage to foster growth       228

6.2.3.3.3 Mineral oils            230

6.2.3.3.3.1              Extensive use of mineral oils as solvents and emollients to propel market   230

6.2.3.4    Acrylic polymers   233

6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market               233

6.2.3.5    Other petrochemicals          235

6.2.4        PROTEINS           238

6.2.4.1    Growing applications of proteins as carriers for microparticles and nanoparticles to propel market   238

6.2.5        OTHER ORGANIC CHEMICALS   241

6.3           INORGANIC CHEMICALS               243

6.3.1        CALCIUM PHOSPHATE 246

6.3.1.1    Chemical purity and low incompatibility with drugs to aid growth                 246

6.3.2        METAL OXIDES 248

6.3.2.1    Availability of silicon oxides in the hydrophobic, hydrophilic, and granulated forms to aid market growth             248

6.3.3        HALITES               250

6.3.3.1    Increased utilization of halites in vaccines and controlled-release formulations to foster growth             250

6.3.4        CALCIUM CARBONATE 253

6.3.4.1    Short disintegration time and excellent mechanical strength to expedite growth    253

6.3.5        CALCIUM SULFATE         255

6.3.5.1    High quality and cost effectiveness to aid growth           255

6.3.6        OTHER INORGANIC CHEMICALS               257

6.4           OTHER CHEMICALS        260

7               PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY             263

7.1           INTRODUCTION              264

7.2           FILLERS & DILUENTS     264

7.2.1        IMPROVED COHESION AND DIRECT COMPRESSION TO AMPLIFY GROWTH          264

7.3           SUSPENDING & VISCOSITY AGENTS        267

7.3.1        DRUG STABILITY AND TASTE MASKING ADVANTAGES TO SUSTAIN GROWTH  267

7.4           COATING AGENTS          270

7.4.1        INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET                 270

7.5           BINDERS              273

7.5.1        HIGHER FLUIDITY AND COMPRESSIBILITY TO STIMULATE GROWTH   273

7.6           FLAVORING AGENTS & SWEETENERS    276

7.6.1        NEED TO IMPROVE DRUG PALATABILITY TO ADVANCE GROWTH             276

7.7           DISINTEGRANTS              279

7.7.1        NEED FOR RAPID BREAK-UP OF SOLID DOSAGE FORMS TO FOSTER GROWTH    279

7.8           COLORANTS      282

7.8.1        INCREASING USE OF COLORING IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO BOOST MARKET     282

7.9           LUBRICANTS & GLIDANTS           285

7.9.1        NON-TOXIC PROPERTIES TO FAVOR GROWTH 285

7.10         PRESERVATIVES               287

7.10.1      GROWING USE OF PRESERVATIVES IN PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY TO DRIVE MARKET 287

7.11         EMULSIFYING AGENTS 290

7.11.1      RISING USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID DRUG FORMULATIONS TO PROMOTE GROWTH             290

7.12         OTHER FUNCTIONALITIES         293

8               PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 297

8.1           INTRODUCTION              298

8.2           ORAL FORMULATIONS 298

8.2.1        TABLETS              301

8.2.1.1    High palatability and portability to support growth        301

8.2.2        CAPSULES           304

8.2.2.1    Hard-gelatin capsules          307

8.2.2.1.1 Ease of manufacturing and versatility to boost market   307

8.2.2.2    Soft-gelatin capsules            309

8.2.2.2.1 Quick-release properties to contribute to growth            309

8.2.3        LIQUID FORMULATIONS              311

8.2.3.1    Rapid absorption from stomach and intestines to foster growth                 311

8.2.4        OTHER ORAL FORMULATIONS 314

8.3           TOPICAL FORMULATIONS          316

8.3.1        GROWING DEMAND FOR TRANSDERMAL PATCHES AND SELF-ADHERING TRANSDERMAL DRUG DELIVERY SYSTEMS TO FUEL MARKET        316

8.4           PARENTERAL FORMULATIONS 319

8.4.1        EMERGENCE OF BIOLOGICAL MOLECULES TO EXPEDITE GROWTH       319

8.5           OTHER FORMULATIONS              323

9               PHARMACEUTICAL EXCIPIENTS MARKET,  BY FUNCTIONALITY APPLICATION                326

9.1           INTRODUCTION              327

9.2           STABILIZERS      327

9.2.1        IMPROVED DRUG SHELF LIFE AND LESSER MANUFACTURING DEFECTS TO PROMOTE GROWTH    327

9.3           TASTE MASKING              330

9.3.1        GROWING PREFERENCE FOR BETTER-TASTING SOLID DOSAGE FORMS TO PROPEL MARKET   330

9.4           MODIFIED-RELEASE      333

9.4.1        INCREASING USE OF MODIFIED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO FOSTER GROWTH                 333

9.5           SOLUBILITY & BIOAVAILABILITY ENHANCEMENT                 336

9.5.1        INCREASING PREFERENCE FOR SOLUBLE COMPOUNDS TO ACCELERATE GROWTH         336

9.6           OTHER APPLICATIONS 339

10            PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION                 342

10.1         INTRODUCTION              343

10.2         EUROPE               343

10.2.1      MACROECONOMIC ANALYSIS FOR EUROPE        344

10.2.2      GERMANY           353

10.2.2.1  Booming pharmaceutical manufacturing sector to aid growth                 353

10.2.3      UK          360

10.2.3.1  Growing adoption of generics and development of novel excipients to fuel market     360

10.2.4      FRANCE                367

10.2.4.1  Large geriatric population to support growth  367

10.2.5      ITALY    374

10.2.5.1  Budgetary constraints and restricted healthcare spending to impede growth      374

10.2.6      SPAIN    381

10.2.6.1  High consumption of biologics to foster growth              381

10.2.7      REST OF EUROPE             388

10.3         NORTH AMERICA             395

10.3.1      MACROECONOMIC ANALYSIS FOR NORTH AMERICA                 395

10.3.2      US           403

10.3.2.1  Well-developed healthcare infrastructure and research bases to aid growth              403

10.3.3      CANADA               410

10.3.3.1  Rising prevalence of cancer to contribute to growth       410

10.4         ASIA PACIFIC     417

10.4.1      MACROECONOMIC ANALYSIS FOR ASIA PACIFIC                 417

10.4.2      CHINA  426

10.4.2.1  Emphasis on generics and off-patent drugs to drive market                 426

10.4.3      JAPAN   433

10.4.3.1  Rapid growth of elderly population to augment growth 433

10.4.4      INDIA    440

10.4.4.1  High domestic demand for pharmaceuticals and export volume to boost market          440

10.4.5      SOUTH KOREA  447

10.4.5.1  Presence of leading contract research and development organizations to propel market           447

10.4.6      REST OF ASIA PACIFIC   454

10.5         LATIN AMERICA                461

10.5.1      GROWING GERIATRIC POPULATION AND RISING DISEASE PREVALENCE ARE DRIVING MARKET GROWTH                 461

10.5.2      MACROECONOMIC ANALYSIS FOR LATIN AMERICA                 461

10.5.3      BRAZIL 469

10.5.3.1  Emerging opportunities for excipient manufacturers to drive market    469

10.5.4      MEXICO                476

10.5.4.1  Growing demand for affordable therapies to boost market                 476

10.5.5      REST OF LATIN AMERICA             483

10.6         MIDDLE EAST   490

10.6.1      GROWING FOCUS ON UNSATURATED MARKETS TO DRIVE MARKET 490

10.6.2      MACROECONOMIC ANALYSIS FOR MIDDLE EAST                 490

10.6.3      GCC COUNTRIES              498

10.6.3.1  Expanding healthcare infrastructure expansion and localization of drug manufacturing to bolster growth          498

10.6.4      REST OF MIDDLE EAST 505

10.7         AFRICA 512

10.7.1      INCREASING PRESENCE OF MAJOR PHARMACEUTICAL COMPANIES TO AUGMENT GROWTH    512

10.7.2      MACROECONOMIC ANALYSIS FOR AFRICA          512

11            COMPETITIVE LANDSCAPE         520

11.1         INTRODUCTION              520

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            520

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2022−2024                 520

11.3         REVENUE ANALYSIS, 2020–2024  521

11.4         MARKET SHARE ANALYSIS, 2024                 522

11.5         COMPANY VALUATION AND FINANCIAL METRICS                 524

11.6         BRAND/PRODUCT COMPARISON             525

11.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 526

11.7.1      STARS   526

11.7.2      EMERGING LEADERS     526

11.7.3      PERVASIVE PLAYERS      526

11.7.4      PARTICIPANTS 526

11.7.5      COMPETITIVE BENCHMARKING: KEY PLAYERS, 2024                 528

11.7.5.1  Company footprint               528

11.7.5.2  Region footprint   529

11.7.5.3  Product footprint  530

11.7.5.4  Functionality footprint         531

11.7.5.5  Functionality application footprint    532

11.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        533

11.8.1      PROGRESSIVE COMPANIES         533

11.8.2      RESPONSIVE COMPANIES            533

11.8.3      DYNAMIC COMPANIES  533

11.8.4      STARTING BLOCKS         533

11.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 535

11.8.5.1  Detailed list of key startups/SMEs    535

11.8.5.2  Competitive benchmarking of key startups/SMEs          536

11.9         COMPETITIVE SCENARIO             536

11.9.1      PRODUCT LAUNCHES AND APPROVALS               536

11.9.2      DEALS  537

11.9.3      EXPANSIONS     539

12            COMPANY PROFILES      540

12.1         KEY PLAYERS     540

12.1.1      INTERNATIONAL FLAVORS & FRAGRANCES INC.                 540

12.1.1.1  Business overview 540

12.1.1.2  Products offered   541

12.1.1.3  Recent developments           543

12.1.1.3.1                Deals      543

12.1.1.3.2                Expansions             543

12.1.1.4  MnM view              544

12.1.1.4.1                Key strengths        544

12.1.1.4.2                Strategic choices   544

12.1.1.4.3                Weaknesses and competitive threats 544

12.1.2      ADM      545

12.1.2.1  Business overview 545

12.1.2.2  Products offered   546

12.1.2.3  Recent developments           547

12.1.2.3.1                Deals      547

12.1.2.4  MnM view              547

12.1.2.4.1                Key strengths        547

12.1.2.4.2                Strategic choices   547

12.1.2.4.3                Weaknesses and competitive threats 547

12.1.3      ROQUETTE FRÈRES        548

12.1.3.1  Business overview 548

12.1.3.2  Products offered   549

12.1.3.3  Recent developments           554

12.1.3.3.1                Product launches and approvals         554

12.1.3.4  MnM view              554

12.1.3.4.1                Key strengths        554

12.1.3.4.2                Strategic choices   555

12.1.3.4.3                Weaknesses and competitive threats 555

12.1.4      BASF SE                 556

12.1.4.1  Business overview 556

12.1.4.2  Products offered   557

12.1.4.3  Recent developments           560

12.1.4.3.1                Deals      560

12.1.4.3.2                Expansions             560

12.1.4.4  MnM view              560

12.1.4.4.1                Key strengths        560

12.1.4.4.2                Strategic choices   560

12.1.4.4.3                Weaknesses and competitive threats 561

12.1.5      EVONIK                562

12.1.5.1  Business overview 562

12.1.5.2  Products offered   563

12.1.5.3  Recent developments           564

12.1.5.3.1                Expansions             564

12.1.5.4  MnM view              564

12.1.5.4.1                Key strengths        564

12.1.5.4.2                Strategic choices   565

12.1.5.4.3                Weaknesses and competitive threats 565

12.1.6      ASHLAND            566

12.1.6.1  Business overview 566

12.1.6.2  Products offered   567

12.1.6.3  Recent developments           569

12.1.6.3.1                Product launches and approvals         569

12.1.7      KERRY GROUP PLC          571

12.1.7.1  Business overview 571

12.1.7.2  Products offered   572

12.1.7.3  Recent developments           573

12.1.7.3.1                Deals      573

12.1.8      MERCK 574

12.1.8.1  Business overview 574

12.1.8.2  Products offered   575

12.1.8.3  Recent developments           577

12.1.8.3.1                Deals      577

12.1.9      ASSOCIATED BRITISH FOODS PLC           578

12.1.9.1  Business overview 578

12.1.9.2  Products offered   579

12.1.9.3  Recent developments           581

12.1.9.3.1                Deals      581

12.1.10   WACKER CHEMIE AG      582

12.1.10.1                 Business overview 582

12.1.10.2                 Products offered   583

12.1.11   AIR LIQUIDE      584

12.1.11.1                 Business overview 584

12.1.11.2                 Products offered   585

12.1.11.3                 Recent developments           587

12.1.11.3.1             Product launches and approvals         587

12.1.12   DOW     588

12.1.12.1                 Business overview 588

12.1.12.2                 Products offered   589

12.1.13   BERKSHIRE HATHAWAY (LUBRIZOL CORPORATION)                 590

12.1.13.1                 Business overview 590

12.1.13.2                 Products offered   591

12.1.13.3                 Recent developments           592

12.1.13.3.1             Product launches and approvals         592

12.1.14   COLORCON, INC.             593

12.1.14.1                 Business overview 593

12.1.14.2                 Products offered   593

12.1.14.3                 Recent developments           594

12.1.14.3.1             Product launches and approvals         594

12.1.14.3.2             Deals      594

12.1.14.3.3             Expansions             595

12.1.15   DFE PHARMA     596

12.1.15.1                 Business overview 596

12.1.15.2                 Products offered   596

12.1.15.3                 Recent developments           598

12.1.15.3.1             Deals      598

12.1.16   ACTYLIS               599

12.1.16.1                 Business overview 599

12.1.16.2                 Products offered   599

12.1.16.3                 Recent developments           604

12.1.16.3.1             Deals      604

12.1.17   CRODA INTERNATIONAL PLC    605

12.1.17.1                 Business overview 605

12.1.17.2                 Products offered   606

12.1.17.3                 Recent developments           607

12.1.17.3.1             Deals      607

12.1.17.3.2             Expansions             607

12.1.18   CHEMIE TRADE                 608

12.1.18.1                 Business overview 608

12.1.18.2                 Products offered   608

12.1.19   GATTEFOSSÉ     609

12.1.19.1                 Business overview 609

12.1.19.2                 Products offered   609

12.1.20   J. RETTENMAIER & SÖHNE GMBH + CO KG          611

12.1.20.1                 Business overview 611

12.1.20.2                 Products offered   611

12.1.21   SHIN-ETSU CHEMICAL CO., LTD.              613

12.1.21.1                 Business overview 613

12.1.21.2                 Products offered   614

12.1.21.3                 Recent developments           615

12.1.21.3.1             Deals      615

12.1.21.3.2             Expansions             615

12.2         OTHER PLAYERS              616

12.2.1      INNOPHOS         616

12.2.2      MEGGLE GMBH & CO. KG             617

12.2.3      FUJI CHEMICAL INDUSTRIES CO., LTD. 618

12.2.4      COREL PHARMA CHEM 618

12.2.5      BIOGRUND         619

12.2.6      NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.                 620

12.2.7      R.T. VANDERBILT HOLDING COMPANY, INC.     621

12.2.8      BENEO 622

12.2.9      SIAGACHI INDUSTRIES 623

12.2.10   JH NANHANG LIFE SCIENCES CO., LTD. 624

13            APPENDIX           625

13.1         DISCUSSION GUIDE        625

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                629

13.3         CUSTOMIZATION OPTIONS        631

13.4         RELATED REPORTS         631

13.5         AUTHOR DETAILS           632

LIST OF TABLES

TABLE 1                PHARMACEUTICAL EXCIPIENTS MARKET: INCLUSIONS AND EXCLUSIONS 63

TABLE 2                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              76

TABLE 3                PHARMACEUTICAL EXCIPIENTS MARKET: RISK ANALYSIS            79

TABLE 4                PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS          88

TABLE 5                IMPENDING AND ONGOING PATENT EXPIRY OF BLOCKBUSTER THERAPEUTICS,  2023–2035        89

TABLE 6                LIST OF MULTIFUNCTIONAL EXCIPIENTS                 94

TABLE 7                INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY KEY PLAYER, 2024             99

TABLE 8                INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY REGION, 2024     100

TABLE 9                PHARMACEUTICAL EXCIPIENTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 104

TABLE 10              PHARMACEUTICAL EXCIPIENTS MARKET: NUMBER OF PATENTS FILED,

2014–2024              108

TABLE 11              INNOVATIONS AND PATENT REGISTRATIONS, 2022–2023              109

TABLE 12              IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (USD)   110

TABLE 13              IMPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (TONS) 110

TABLE 14              EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (USD)   111

TABLE 15              EXPORT DATA FOR HS CODE 290545 (GLYCEROL), 2020–2024 (TONS) 111

TABLE 16              IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (USD)             112

TABLE 17              IMPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES),

2020–2024 (TONS)             112

TABLE 18              EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES), 2020–2024 (USD)             113

TABLE 19              EXPORT DATA FOR HS CODE 350510 (DEXTRINS AND OTHER MODIFIED STARCHES, E.G. PREGELATINISED OR ESTERIFIED STARCHES),

2020–2024 (TONS)             113

TABLE 20              IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL “PROPANE-1,2-DIOL),  2020–2024 (USD)                 114

TABLE 21              IMPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL “PROPANE-1,2-DIOL),  2020–2024 (TONS)                 114

TABLE 22              EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL “PROPANE-1,2-DIOL),  2020–2024 (USD)                 115

TABLE 23              EXPORT DATA FOR HS CODE 290532 (PROPYLENE GLYCOL “PROPANE-1,2-DIOL),  2020–2024 (TONS)                 115

TABLE 24              IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (USD) 116

TABLE 25              IMPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (TONS)               116

TABLE 26              EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (USD) 117

TABLE 27              EXPORT DATA FOR HS CODE 283650 (CALCIUM CARBONATE), 2020–2024 (TONS)               117

TABLE 28              IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (USD)     118

TABLE 29              IMPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (TONS)  118

TABLE 30              EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (USD)     119

TABLE 31              EXPORT DATA FOR HS CODE 250100 (SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE), 2020–2024 (TONS)  119

TABLE 32              IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (USD)  120

TABLE 33              IMPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (TONS)                120

TABLE 34              EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (USD)  121

TABLE 35              EXPORT DATA FOR HS CODE 290543 (MANNITOL), 2020–2024 (TONS)                121

TABLE 36              IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (USD)                122

TABLE 37              IMPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (TONS)             122

TABLE 38              EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (USD)                123

TABLE 39              EXPORT DATA FOR HS CODE: 3912 (CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS), 2020–2024 (TONS)             123

TABLE 40              PHARMACEUTICAL EXCIPIENTS MARKET: KEY CONFERENCES AND EVENTS,

2025–2026              124

TABLE 41              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 128

TABLE 42              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           128

TABLE 43              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 129

TABLE 44              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 129

TABLE 45              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 130

TABLE 46              PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS           130

TABLE 47              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)      133

TABLE 48              KEY BUYING CRITERIA, BY END USER    134

TABLE 49              US ADJUSTED RECIPROCAL TARIFF RATES                 138

TABLE 50              COMPARATIVE PRICING ON KEY EXCIPIENT PRE AND POST US 2025 TARIFF 139

TABLE 51              IMPACT ANALYSIS ON END-USE INDUSTRIES                 141

TABLE 52              PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            143

TABLE 53              PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 144

TABLE 54              PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION,  2023–2030 (USD MILLION)                 144

TABLE 55              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)     144

TABLE 56              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               145

TABLE 57              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION) 145

TABLE 58              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)     145

TABLE 59              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY REGION, 2023–2030 (USD MILLION) 146

TABLE 60              PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,

2023–2030 (USD MILLION)            146

TABLE 61              PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY REGION,  2023–2030 (USD MILLION)                 147

TABLE 62              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            147

TABLE 63              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               147

TABLE 64              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 65              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            148

TABLE 66              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY REGION, 2023–2030 (USD MILLION)   148

TABLE 67              PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS, BY REGION,  2023–2030 (USD MILLION)                 149

TABLE 68              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)            150

TABLE 69              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 70              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 71              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)            151

TABLE 72              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FATTY ALCOHOLS,

BY REGION, 2023–2030 (USD MILLION)   151

TABLE 73              PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES, BY REGION,  2023–2030 (USD MILLION)                 152

TABLE 74              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES,  BY COUNTRY, 2023–2030 (USD MILLION)     152

TABLE 75              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 76              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES,  BY COUNTRY, 2023–2030 (USD MILLION) 153

TABLE 77              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES,  BY COUNTRY, 2023–2030 (USD MILLION)     153

TABLE 78              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL STEARATES,  BY REGION, 2023–2030 (USD MILLION) 153

TABLE 79              PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY REGION,

2023–2030 (USD MILLION)            154

TABLE 80              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN,

BY COUNTRY, 2023–2030 (USD MILLION)               154

TABLE 81              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN, BY COUNTRY,  2023–2030 (USD MILLION)            155

TABLE 82              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 83              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 84              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCERIN,

BY REGION, 2023–2030 (USD MILLION)   156

TABLE 85              PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY REGION, 2023–2030 (USD MILLION)            156

TABLE 86              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     157

TABLE 87              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)       157

TABLE 88              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)       157

TABLE 89              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     158

TABLE 90              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER OLEOCHEMICALS,  BY REGION, 2023–2030 (USD MILLION) 158

TABLE 91              PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 92              PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY REGION,  2023–2030 (USD MILLION)                 159

TABLE 93              NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,  BY COUNTRY, 2023–2030 (USD MILLION)            159

TABLE 94              EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY COUNTRY, 2023–2030 (USD MILLION)               160

TABLE 95              ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY COUNTRY, 2023–2030 (USD MILLION)               160

TABLE 96              LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,  BY COUNTRY, 2023–2030 (USD MILLION)            160

TABLE 97              MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY REGION, 2023–2030 (USD MILLION)   161

TABLE 98              PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            161

TABLE 99              PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY REGION,

2023–2030 (USD MILLION)            162

TABLE 100            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS,

BY COUNTRY, 2023–2030 (USD MILLION)               162

TABLE 101            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY,  2023–2030 (USD MILLION)            162

TABLE 102            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY COUNTRY, 2023–2030 (USD MILLION)                 163

TABLE 103            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 104            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY REGION,  2023–2030 (USD MILLION)                 163

TABLE 105            PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,

2023–2030 (USD MILLION)            165

TABLE 106            PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY REGION,

2023–2030 (USD MILLION)            165

TABLE 107            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,  BY COUNTRY, 2023–2030 (USD MILLION)            165

TABLE 108            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 109            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 110            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 111            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY REGION, 2023–2030 (USD MILLION)   167

TABLE 112            PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY REGION,

2023–2030 (USD MILLION)            167

TABLE 113            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE,

BY COUNTRY, 2023–2030 (USD MILLION)               168

TABLE 114            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY,  2023–2030 (USD MILLION)            168

TABLE 115            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY COUNTRY, 2023–2030 (USD MILLION)            168

TABLE 116            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 117            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LACTOSE, BY REGION,  2023–2030 (USD MILLION)                 169

TABLE 118            PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY REGION,

2023–2030 (USD MILLION)            170

TABLE 119            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 120            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY COUNTRY,  2023–2030 (USD MILLION)            170

TABLE 121            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 122            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 123            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUCROSE, BY REGION, 2023–2030 (USD MILLION)                 171

TABLE 124            PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE), BY REGION, 2023–2030 (USD MILLION)            172

TABLE 125            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE

(D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION)                 172

TABLE 126            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE (D-GLUCOSE),  BY COUNTRY, 2023–2030 (USD MILLION)       173

TABLE 127            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE

(D-GLUCOSE),  BY COUNTRY, 2023–2030 (USD MILLION)                 173

TABLE 128            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE

(D-GLUCOSE), BY COUNTRY, 2023–2030 (USD MILLION)                 173

TABLE 129            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DEXTROSE

(D-GLUCOSE),  BY REGION, 2023–2030 (USD MILLION) 174

TABLE 130            PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,

2023–2030 (USD MILLION)            175

TABLE 131            PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY REGION,  2023–2030 (USD MILLION)                 175

TABLE 132            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)            175

TABLE 133            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               176

TABLE 134            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               176

TABLE 135            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)            176

TABLE 136            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY REGION, 2023–2030 (USD MILLION)   177

TABLE 137            PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY REGION,

2023–2030 (USD MILLION)            177

TABLE 138            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               178

TABLE 139            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL, BY COUNTRY,  2023–2030 (USD MILLION)            178

TABLE 140            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               178

TABLE 141            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 142            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SORBITOL,

BY REGION, 2023–2030 (USD MILLION)   179

TABLE 143            PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY REGION,

2023–2030 (USD MILLION)            180

TABLE 144            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 145            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL, BY COUNTRY,  2023–2030 (USD MILLION)            180

TABLE 146            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 147            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 148            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MANNITOL,

BY REGION, 2023–2030 (USD MILLION)   181

TABLE 149            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS,

BY REGION, 2023–2030 (USD MILLION)   182

TABLE 150            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION)     182

TABLE 151            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)       183

TABLE 152            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS,  BY COUNTRY, 2023–2030 (USD MILLION)       183

TABLE 153            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS, BY COUNTRY, 2023–2030 (USD MILLION)     183

TABLE 154            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER SUGAR ALCOHOLS,  BY REGION, 2023–2030 (USD MILLION)       184

TABLE 155            PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS,

BY REGION, 2023–2030 (USD MILLION)   185

TABLE 156            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)     185

TABLE 157            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)       185

TABLE 158            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS,  BY COUNTRY, 2023–2030 (USD MILLION)       186

TABLE 159            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)     186

TABLE 160            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ARTIFICIAL SWEETENERS, BY REGION, 2023–2030 (USD MILLION) 186

TABLE 161            PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            187

TABLE 162            PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY REGION,

2023–2030 (USD MILLION)            188

TABLE 163            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY COUNTRY, 2023–2030 (USD MILLION)               188

TABLE 164            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY COUNTRY,  2023–2030 (USD MILLION)            188

TABLE 165            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY COUNTRY, 2023–2030 (USD MILLION)               189

TABLE 166            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY COUNTRY, 2023–2030 (USD MILLION)               189

TABLE 167            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY REGION, 2023–2030 (USD MILLION)   189

TABLE 168            PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE,

BY REGION, 2023–2030 (USD MILLION)   190

TABLE 169            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION)     191

TABLE 170            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION)            191

TABLE 171            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION)            191

TABLE 172            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2023–2030 (USD MILLION)     192

TABLE 173            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MICROCRYSTALLINE CELLULOSE, BY REGION, 2023–2030 (USD MILLION)            192

TABLE 174            PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS, BY REGION,  2023–2030 (USD MILLION)                 193

TABLE 175            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS,  BY COUNTRY, 2023–2030 (USD MILLION)            193

TABLE 176            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS,

BY COUNTRY, 2023–2030 (USD MILLION)               194

TABLE 177            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS,  BY COUNTRY, 2023–2030 (USD MILLION) 194

TABLE 178            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS,  BY COUNTRY, 2023–2030 (USD MILLION)            194

TABLE 179            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ETHERS,  BY REGION, 2023–2030 (USD MILLION) 195

TABLE 180            PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM,  BY REGION, 2023–2030 (USD MILLION) 196

TABLE 181            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION)               196

TABLE 182            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION)            196

TABLE 183            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION)            197

TABLE 184            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 185            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CMC & CROSCARMELLOSE SODIUM, BY REGION, 2023–2030 (USD MILLION)            197

TABLE 186            PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS, BY REGION,  2023–2030 (USD MILLION)                 198

TABLE 187            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS,  BY COUNTRY, 2023–2030 (USD MILLION)            198

TABLE 188            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               199

TABLE 189            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS,  BY COUNTRY, 2023–2030 (USD MILLION) 199

TABLE 190            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS,  BY COUNTRY, 2023–2030 (USD MILLION)            199

TABLE 191            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE ESTERS,  BY REGION, 2023–2030 (USD MILLION)            200

TABLE 192            PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            200

TABLE 193            PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY REGION,

2023–2030 (USD MILLION)            201

TABLE 194            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               201

TABLE 195            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY,  2023–2030 (USD MILLION)            201

TABLE 196            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 202

TABLE 197            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               202

TABLE 198            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY REGION,  2023–2030 (USD MILLION)                 202

TABLE 199            PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH, BY REGION,  2023–2030 (USD MILLION)                 203

TABLE 200            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH,  BY COUNTRY, 2023–2030 (USD MILLION)            204

TABLE 201            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 202            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 203            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH,  BY COUNTRY, 2023–2030 (USD MILLION)            205

TABLE 204            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED STARCH,  BY REGION, 2023–2030 (USD MILLION)            205

TABLE 205            PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH, BY REGION,

2023–2030 (USD MILLION)          206

TABLE 206            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 207            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 208            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               207

TABLE 209            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               207

TABLE 210            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DRIED STARCH,

BY REGION, 2023–2030 (USD MILLION)   207

TABLE 211            PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH, BY REGION,  2023–2030 (USD MILLION)                 208

TABLE 212            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH,  BY COUNTRY, 2023–2030 (USD MILLION)     208

TABLE 213            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               209

TABLE 214            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH,  BY COUNTRY, 2023–2030 (USD MILLION) 209

TABLE 215            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH,  BY COUNTRY, 2023–2030 (USD MILLION)     209

TABLE 216            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CONVERTED STARCH,  BY REGION, 2023–2030 (USD MILLION) 210

TABLE 217            PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,

2023–2030 (USD MILLION)            210

TABLE 218            PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY REGION,  2023–2030 (USD MILLION)                 211

TABLE 219            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            211

TABLE 220            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               211

TABLE 221            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 222            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            212

TABLE 223            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY REGION, 2023–2030 (USD MILLION)            212

TABLE 224            PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            213

TABLE 225            PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY REGION,

2023–2030 (USD MILLION)          214

TABLE 226            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 227            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY COUNTRY, 2023–2030 (USD MILLION)            214

TABLE 228            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               215

TABLE 229            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY COUNTRY, 2023–2030 (USD MILLION)               215

TABLE 230            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY REGION, 2023–2030 (USD MILLION)                 215

TABLE 231            PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY REGION,  2023–2030 (USD MILLION)            216

TABLE 232            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL, BY COUNTRY, 2023–2030 (USD MILLION)     216

TABLE 233            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION)       217

TABLE 234            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION)       217

TABLE 235            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION)     217

TABLE 236            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POLYETHYLENE GLYCOL,  BY REGION, 2023–2030 (USD MILLION) 218

TABLE 237            PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL, BY REGION,  2023–2030 (USD MILLION)                 218

TABLE 238            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION)            219

TABLE 239            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 240            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION) 219

TABLE 241            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL,  BY COUNTRY, 2023–2030 (USD MILLION)            220

TABLE 242            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROPYLENE GLYCOL,  BY REGION, 2023–2030 (USD MILLION) 220

TABLE 243            PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY REGION,

2023–2030 (USD MILLION)            221

TABLE 244            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES,

BY COUNTRY, 2023–2030 (USD MILLION)               221

TABLE 245            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES, BY COUNTRY,  2023–2030 (USD MILLION)            221

TABLE 246            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 247            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES,

BY COUNTRY, 2023–2030 (USD MILLION)               222

TABLE 248            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR POVIDONES,

BY REGION, 2023–2030 (USD MILLION)   222

TABLE 249            PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE,  2023–2030 (USD MILLION)            223

TABLE 250            PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,

BY REGION, 2023–2030 (USD MILLION)   224

TABLE 251            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION)     224

TABLE 252            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY COUNTRY, 2023–2030 (USD MILLION)       224

TABLE 253            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION)       225

TABLE 254            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY COUNTRY, 2023–2030 (USD MILLION)     225

TABLE 255            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY REGION, 2023–2030 (USD MILLION)       225

TABLE 256            PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM, BY REGION,

2023–2030 (USD MILLION)            226

TABLE 257            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 258            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 259            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 260            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 261            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROLATUM,

BY REGION, 2023–2030 (USD MILLION)   228

TABLE 262            PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES, BY REGION,  2023–2030 (USD MILLION)                 228

TABLE 263            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES,  BY COUNTRY, 2023–2030 (USD MILLION)            229

TABLE 264            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES,

BY COUNTRY, 2023–2030 (USD MILLION)               229

TABLE 265            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES,

BY COUNTRY, 2023–2030 (USD MILLION)               229

TABLE 266            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES,  BY COUNTRY, 2023–2030 (USD MILLION)            230

TABLE 267            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL WAXES,

BY REGION, 2023–2030 (USD MILLION)   230

TABLE 268            PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS, BY REGION,

2023–2030 (USD MILLION)            231

TABLE 269            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS,

BY COUNTRY, 2023–2030 (USD MILLION)               231

TABLE 270            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS,

BY COUNTRY, 2023–2030 (USD MILLION)               231

TABLE 271            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 272            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 273            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL OILS,

BY REGION, 2023–2030 (USD MILLION)   232

TABLE 274            PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS, BY REGION,  2023–2030 (USD MILLION)                 233

TABLE 275            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS,  BY COUNTRY, 2023–2030 (USD MILLION)            234

TABLE 276            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 277            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS,  BY COUNTRY, 2023–2030 (USD MILLION) 234

TABLE 278            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS,  BY COUNTRY, 2023–2030 (USD MILLION)            235

TABLE 279            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACRYLIC POLYMERS,  BY REGION, 2023–2030 (USD MILLION) 235

TABLE 280            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS,

BY REGION, 2023–2030 (USD MILLION)   236

TABLE 281            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     236

TABLE 282            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)       237

TABLE 283            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)       237

TABLE 284            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     237

TABLE 285            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER PETROCHEMICALS,  BY REGION, 2023–2030 (USD MILLION)       238

TABLE 286            PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY REGION,

2023–2030 (USD MILLION)            239

TABLE 287            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 288            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS, BY COUNTRY,  2023–2030 (USD MILLION)            239

TABLE 289            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 290            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS,

BY COUNTRY, 2023–2030 (USD MILLION)               240

TABLE 291            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PROTEINS,

BY REGION, 2023–2030 (USD MILLION)   240

TABLE 292            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS,

BY REGION, 2023–2030 (USD MILLION)   241

TABLE 293            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     241

TABLE 294            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            242

TABLE 295            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            242

TABLE 296            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     242

TABLE 297            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION)       243

TABLE 298            PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 243

TABLE 299            PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION)                 244

TABLE 300            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     244

TABLE 301            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               244

TABLE 302            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)       245

TABLE 303            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     245

TABLE 304            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY REGION, 2023–2030 (USD MILLION) 245

TABLE 305            PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE, BY REGION,  2023–2030 (USD MILLION)                 246

TABLE 306            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE,  BY COUNTRY, 2023–2030 (USD MILLION)     246

TABLE 307            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE,

BY COUNTRY, 2023–2030 (USD MILLION)               247

TABLE 308            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE,  BY COUNTRY, 2023–2030 (USD MILLION) 247

TABLE 309            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE,  BY COUNTRY, 2023–2030 (USD MILLION)     247

TABLE 310            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM PHOSPHATE,  BY REGION, 2023–2030 (USD MILLION) 248

TABLE 311            PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES, BY REGION,

2023–2030 (USD MILLION)            248

TABLE 312            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES,

BY COUNTRY, 2023–2030 (USD MILLION)             249

TABLE 313            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 314            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 315            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES,

BY COUNTRY, 2023–2030 (USD MILLION)             250

TABLE 316            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR METAL OXIDES,

BY REGION, 2023–2030 (USD MILLION)   250

TABLE 317            PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY REGION,

2023–2030 (USD MILLION)            251

TABLE 318            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 319            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY,  2023–2030 (USD MILLION)            251

TABLE 320            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY COUNTRY, 2023–2030 (USD MILLION)                 252

TABLE 321            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES,

BY COUNTRY, 2023–2030 (USD MILLION)               252

TABLE 322            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HALITES, BY REGION,  2023–2030 (USD MILLION)                 252

TABLE 323            PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE, BY REGION,  2023–2030 (USD MILLION)                 253

TABLE 324            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE,  BY COUNTRY, 2023–2030 (USD MILLION)     253

TABLE 325            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE,

BY COUNTRY, 2023–2030 (USD MILLION)               254

TABLE 326            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE,  BY COUNTRY, 2023–2030 (USD MILLION) 254

TABLE 327            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE,  BY COUNTRY, 2023–2030 (USD MILLION)     254

TABLE 328            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM CARBONATE,  BY REGION, 2023–2030 (USD MILLION) 255

TABLE 329            PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE, BY REGION,  2023–2030 (USD MILLION)                 255

TABLE 330            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE,  BY COUNTRY, 2023–2030 (USD MILLION)            256

TABLE 331            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 332            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE,

BY COUNTRY, 2023–2030 (USD MILLION)               256

TABLE 333            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE,  BY COUNTRY, 2023–2030 (USD MILLION)            257

TABLE 334            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CALCIUM SULFATE,  BY REGION, 2023–2030 (USD MILLION)            257

TABLE 335            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS,

BY REGION, 2023–2030 (USD MILLION)   258

TABLE 336            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     258

TABLE 337            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            258

TABLE 338            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            259

TABLE 339            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)     259

TABLE 340            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER INORGANIC CHEMICALS, BY REGION, 2023–2030 (USD MILLION)            259

TABLE 341            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION,  2023–2030 (USD MILLION)                 260

TABLE 342            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,  BY COUNTRY, 2023–2030 (USD MILLION)            260

TABLE 343            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               261

TABLE 344            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,

BY COUNTRY, 2023–2030 (USD MILLION)               261

TABLE 345            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)            261

TABLE 346            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS,  BY REGION, 2023–2030 (USD MILLION)            262

TABLE 347            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            264

TABLE 348            PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS, BY REGION,  2023–2030 (USD MILLION)                 265

TABLE 349            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,  BY COUNTRY, 2023–2030 (USD MILLION)            266

TABLE 350            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               266

TABLE 351            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,  BY COUNTRY, 2023–2030 (USD MILLION) 266

TABLE 352            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,  BY COUNTRY, 2023–2030 (USD MILLION)            267

TABLE 353            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FILLERS & DILUENTS,  BY REGION, 2023–2030 (USD MILLION) 267

TABLE 354            PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS,  BY REGION, 2023–2030 (USD MILLION) 268

TABLE 355            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)               268

TABLE 356            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)            269

TABLE 357            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)            269

TABLE 358            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2023–2030 (USD MILLION)               269

TABLE 359            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUSPENDING & VISCOSITY AGENTS, BY REGION, 2023–2030 (USD MILLION)            270

TABLE 360            PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS, BY REGION,  2023–2030 (USD MILLION)                 271

TABLE 361            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,  BY COUNTRY, 2023–2030 (USD MILLION)            272

TABLE 362            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               272

TABLE 363            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               272

TABLE 364            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,  BY COUNTRY, 2023–2030 (USD MILLION)            273

TABLE 365            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COATING AGENTS,

BY REGION, 2023–2030 (USD MILLION)   273

TABLE 366            PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION,

2023–2030 (USD MILLION)            274

TABLE 367            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,

BY COUNTRY, 2023–2030 (USD MILLION)               275

TABLE 368            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY COUNTRY,  2023–2030 (USD MILLION)            275

TABLE 369            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,

BY COUNTRY, 2023–2030 (USD MILLION)               275

TABLE 370            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS,

BY COUNTRY, 2023–2030 (USD MILLION)               276

TABLE 371            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR BINDERS, BY REGION,  2023–2030 (USD MILLION)                 276

TABLE 372            PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS,  BY REGION, 2023–2030 (USD MILLION) 277

TABLE 373            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)               277

TABLE 374            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)     278

TABLE 375            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)     278

TABLE 376            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY COUNTRY, 2023–2030 (USD MILLION)               278

TABLE 377            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR FLAVORING AGENTS & SWEETENERS, BY REGION, 2023–2030 (USD MILLION)            279

TABLE 378            PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS, BY REGION,

2023–2030 (USD MILLION)            280

TABLE 379            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,  BY COUNTRY, 2023–2030 (USD MILLION)            280

TABLE 380            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               280

TABLE 381            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               281

TABLE 382            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               281

TABLE 383            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR DISINTEGRANTS,

BY REGION, 2023–2030 (USD MILLION) 281

TABLE 384            PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY REGION,

2023–2030 (USD MILLION)          283

TABLE 385            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               283

TABLE 386            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS, BY COUNTRY, 2023–2030 (USD MILLION)            283

TABLE 387            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               284

TABLE 388            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,

BY COUNTRY, 2023–2030 (USD MILLION)               284

TABLE 389            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR COLORANTS,

BY REGION, 2023–2030 (USD MILLION)   284

TABLE 390            PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,

BY REGION,  2023–2030 (USD MILLION)                 285

TABLE 391            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION)     286

TABLE 392            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,  BY COUNTRY, 2023–2030 (USD MILLION)       286

TABLE 393            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,  BY COUNTRY, 2023–2030 (USD MILLION)       286

TABLE 394            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS, BY COUNTRY, 2023–2030 (USD MILLION)     287

TABLE 395            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LUBRICANTS & GLIDANTS,  BY REGION, 2023–2030 (USD MILLION)       287

TABLE 396            PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES, BY REGION,

2023–2030 (USD MILLION)            288

TABLE 397            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,  BY COUNTRY, 2023–2030 (USD MILLION)            288

TABLE 398            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,

BY COUNTRY, 2023–2030 (USD MILLION)               289

TABLE 399            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,

BY COUNTRY, 2023–2030 (USD MILLION)               289

TABLE 400            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,

BY COUNTRY, 2023–2030 (USD MILLION)             289

TABLE 401            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PRESERVATIVES,

BY REGION, 2023–2030 (USD MILLION)   290

TABLE 402            PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION,  2023–2030 (USD MILLION)                 291

TABLE 403            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS,  BY COUNTRY, 2023–2030 (USD MILLION)     291

TABLE 404            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               291

TABLE 405            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS,  BY COUNTRY, 2023–2030 (USD MILLION) 292

TABLE 406            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS,  BY COUNTRY, 2023–2030 (USD MILLION)     292

TABLE 407            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR EMULSIFYING AGENTS, BY REGION, 2023–2030 (USD MILLION) 292

TABLE 408            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,

BY REGION,  2023–2030 (USD MILLION)                 294

TABLE 409            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION)     294

TABLE 410            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,  BY COUNTRY, 2023–2030 (USD MILLION)       295

TABLE 411            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,  BY COUNTRY, 2023–2030 (USD MILLION)       295

TABLE 412            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2023–2030 (USD MILLION)     295

TABLE 413            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES,  BY REGION, 2023–2030 (USD MILLION)       296

TABLE 414            PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            298

TABLE 415            PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE,  2023–2030 (USD MILLION)                 299

TABLE 416            PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION,  2023–2030 (USD MILLION)                 299

TABLE 417            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)     299

TABLE 418            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               300

TABLE 419            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION) 300

TABLE 420            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)     300

TABLE 421            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY REGION, 2023–2030 (USD MILLION) 301

TABLE 422            TYPICAL COMPOSITION OF TABLETS    301

TABLE 423            PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION,

2023–2030 (USD MILLION)            302

TABLE 424            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS,

BY COUNTRY, 2023–2030 (USD MILLION)               302

TABLE 425            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY,  2023–2030 (USD MILLION)            303

TABLE 426            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY COUNTRY, 2023–2030 (USD MILLION)                 303

TABLE 427            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS,

BY COUNTRY, 2023–2030 (USD MILLION)               303

TABLE 428            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLETS, BY REGION,  2023–2030 (USD MILLION)                 304

TABLE 429            PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 430            PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY REGION,

2023–2030 (USD MILLION)            305

TABLE 431            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY COUNTRY, 2023–2030 (USD MILLION)               305

TABLE 432            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY COUNTRY,  2023–2030 (USD MILLION)            305

TABLE 433            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY COUNTRY, 2023–2030 (USD MILLION)               306

TABLE 434            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY COUNTRY, 2023–2030 (USD MILLION)             306

TABLE 435            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY REGION, 2023–2030 (USD MILLION)   306

TABLE 436            PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES,

BY REGION, 2023–2030 (USD MILLION)   307

TABLE 437            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION)     307

TABLE 438            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES,  BY COUNTRY, 2023–2030 (USD MILLION)       308

TABLE 439            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION)       308

TABLE 440            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION)     308

TABLE 441            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD-GELATIN CAPSULES, BY REGION, 2023–2030 (USD MILLION) 309

TABLE 442            PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES,

BY REGION, 2023–2030 (USD MILLION)   309

TABLE 443            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION)     310

TABLE 444            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES,  BY COUNTRY, 2023–2030 (USD MILLION)       310

TABLE 445            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES,  BY COUNTRY, 2023–2030 (USD MILLION)       310

TABLE 446            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES, BY COUNTRY, 2023–2030 (USD MILLION)     311

TABLE 447            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT-GELATIN CAPSULES,  BY REGION, 2023–2030 (USD MILLION)       311

TABLE 448            PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY REGION,  2023–2030 (USD MILLION)            312

TABLE 449            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     312

TABLE 450            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)             312

TABLE 451            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)       313

TABLE 452            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     313

TABLE 453            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS,  BY REGION, 2023–2030 (USD MILLION) 313

TABLE 454            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS,

BY REGION, 2023–2030 (USD MILLION)   314

TABLE 455            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     315

TABLE 456            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)            315

TABLE 457            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            315

TABLE 458            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     316

TABLE 459            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER ORAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION)       316

TABLE 460            PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS,

BY REGION,  2023–2030 (USD MILLION)                 317

TABLE 461            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     317

TABLE 462            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)       318

TABLE 463            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       318

TABLE 464            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     318

TABLE 465            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS,  BY REGION, 2023–2030 (USD MILLION)       319

TABLE 466            TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS              319

TABLE 467            EXCIPIENTS USED IN PARENTERAL FORMULATIONS              320

TABLE 468            PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS,

BY REGION, 2023–2030 (USD MILLION)   321

TABLE 469            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     321

TABLE 470            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)            321

TABLE 471            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            322

TABLE 472            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     322

TABLE 473            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2023–2030 (USD MILLION)       322

TABLE 474            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION,  2023–2030 (USD MILLION)            323

TABLE 475            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     323

TABLE 476            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               324

TABLE 477            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)       324

TABLE 478            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)     324

TABLE 479            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS,  BY REGION, 2023–2030 (USD MILLION) 325

TABLE 480            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,

2023–2030 (USD MILLION)            327

TABLE 481            PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION,

2023–2030 (USD MILLION)            328

TABLE 482            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               328

TABLE 483            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY,  2023–2030 (USD MILLION)            329

TABLE 484            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               329

TABLE 485            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS,

BY COUNTRY, 2023–2030 (USD MILLION)               329

TABLE 486            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS,

BY REGION, 2023–2030 (USD MILLION)   330

TABLE 487            PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION,

2023–2030 (USD MILLION)            331

TABLE 488            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING,  BY COUNTRY, 2023–2030 (USD MILLION)            331

TABLE 489            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING,

BY COUNTRY, 2023–2030 (USD MILLION)               331

TABLE 490            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING,

BY COUNTRY, 2023–2030 (USD MILLION)               332

TABLE 491            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING,

BY COUNTRY, 2023–2030 (USD MILLION)               332

TABLE 492            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING,

BY REGION, 2023–2030 (USD MILLION)   332

TABLE 493            PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE, BY REGION,  2023–2030 (USD MILLION)                 334

TABLE 494            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE,  BY COUNTRY, 2023–2030 (USD MILLION)            334

TABLE 495            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE,

BY COUNTRY, 2023–2030 (USD MILLION)               334

TABLE 496            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE,  BY COUNTRY, 2023–2030 (USD MILLION) 335

TABLE 497            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE,  BY COUNTRY, 2023–2030 (USD MILLION)            335

TABLE 498            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED-RELEASE,  BY REGION, 2023–2030 (USD MILLION) 335

TABLE 499            PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY,

BY REGION, 2023–2030 (USD MILLION)   337

TABLE 500            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION)     337

TABLE 501            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY,  BY COUNTRY, 2023–2030 (USD MILLION)            337

TABLE 502            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION)            338

TABLE 503            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2023–2030 (USD MILLION)     338

TABLE 504            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2023–2030 (USD MILLION)            338

TABLE 505            PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS, BY REGION,  2023–2030 (USD MILLION)                 339

TABLE 506            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)     340

TABLE 507            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               340

TABLE 508            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2023–2030 (USD MILLION) 340

TABLE 509            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2023–2030 (USD MILLION)     341

TABLE 510            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER APPLICATIONS,  BY REGION, 2023–2030 (USD MILLION) 341

TABLE 511            PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2030 (USD MILLION)          343

TABLE 512            EUROPE: KEY MACROECONOMIC INDICATORS                 345

TABLE 513            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          346

TABLE 514            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            346

TABLE 515            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         346

TABLE 516            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            347

TABLE 517            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            347

TABLE 518            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            347

TABLE 519            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            348

TABLE 520            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY TYPE, 2023–2030 (USD MILLION)         348

TABLE 521            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 348

TABLE 522            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            349

TABLE 523            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         349

TABLE 524            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            349

TABLE 525            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 350

TABLE 526            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         350

TABLE 527            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            351

TABLE 528            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            351

TABLE 529            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         352

TABLE 530            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 352

TABLE 531            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            352

TABLE 532            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            353

TABLE 533            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 534            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 535            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 536            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 355

TABLE 537            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         355

TABLE 538            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY TYPE, 2023–2030 (USD MILLION)         355

TABLE 539            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 356

TABLE 540            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            356

TABLE 541            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         356

TABLE 542            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,  2023–2030 (USD MILLION)                 357

TABLE 543            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 357

TABLE 544            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION) 357

TABLE 545            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            358

TABLE 546            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            358

TABLE 547            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         359

TABLE 548            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 359

TABLE 549            GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            359

TABLE 550            UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            360

TABLE 551            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            361

TABLE 552            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 361

TABLE 553            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)                 361

TABLE 554            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            362

TABLE 555            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 362

TABLE 556            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)                 362

TABLE 557            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            363

TABLE 558            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            363

TABLE 559            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 363

TABLE 560            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            364

TABLE 561            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,

BY TYPE, 2023–2030 (USD MILLION)         364

TABLE 562            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         364

TABLE 563            UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            365

TABLE 564            UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            365

TABLE 565            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE,  2023–2030 (USD MILLION)            366

TABLE 566            UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            366

TABLE 567            UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)                 366

TABLE 568            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            367

TABLE 569            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         368

TABLE 570            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            368

TABLE 571            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            368

TABLE 572            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            369

TABLE 573            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION)            369

TABLE 574            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)            369

TABLE 575            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 370

TABLE 576            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            370

TABLE 577            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         370

TABLE 578            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            371

TABLE 579            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 371

TABLE 580            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         371

TABLE 581            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            372

TABLE 582            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            372

TABLE 583            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         373

TABLE 584            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 373

TABLE 585            FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            373

TABLE 586            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            374

TABLE 587            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         375

TABLE 588            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            375

TABLE 589            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            375

TABLE 590            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 591            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            376

TABLE 592            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            376

TABLE 593            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)          377

TABLE 594            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            377

TABLE 595            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            377

TABLE 596            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            378

TABLE 597            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,

BY TYPE, 2023–2030 (USD MILLION)         378

TABLE 598            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         378

TABLE 599            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            379

TABLE 600            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            379

TABLE 601            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         380

TABLE 602            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 603            ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            380

TABLE 604            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            381

TABLE 605            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         382

TABLE 606            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            382

TABLE 607            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            382

TABLE 608            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 609            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            383

TABLE 610            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            383

TABLE 611            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            384

TABLE 612            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            384

TABLE 613            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            384

TABLE 614            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            385

TABLE 615            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 385

TABLE 616            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         385

TABLE 617            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            386

TABLE 618            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            386

TABLE 619            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         387

TABLE 620            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            387

TABLE 621            SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            387

TABLE 622            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            388

TABLE 623            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            389

TABLE 624            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       389

TABLE 625            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,  BY TYPE, 2023–2030 (USD MILLION)       389

TABLE 626            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)            390

TABLE 627            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,  BY TYPE, 2023–2030 (USD MILLION)       390

TABLE 628            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY TYPE, 2023–2030 (USD MILLION)       390

TABLE 629            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY TYPE, 2023–2030 (USD MILLION)         391

TABLE 630            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)            391

TABLE 631            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       391

TABLE 632            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY TYPE, 2023–2030 (USD MILLION)         392

TABLE 633            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            392

TABLE 634            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            392

TABLE 635            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)            393

TABLE 636            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)            393

TABLE 637            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            394

TABLE 638            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY TYPE,  2023–2030 (USD MILLION)      394

TABLE 639            REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)       394

TABLE 640            NORTH AMERICA: KEY MACROECONOMIC INDICATORS      396

TABLE 641            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            396

TABLE 642            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            397

TABLE 643            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            397

TABLE 644            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       397

TABLE 645            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,  BY TYPE, 2023–2030 (USD MILLION)       398

TABLE 646            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)            398

TABLE 647            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,  BY TYPE, 2023–2030 (USD MILLION)       398

TABLE 648            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY TYPE, 2023–2030 (USD MILLION)       399

TABLE 649            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY TYPE, 2023–2030 (USD MILLION)         399

TABLE 650            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)            399

TABLE 651            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       400

TABLE 652            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION)            400

TABLE 653            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            400

TABLE 654            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            401

TABLE 655            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)            401

TABLE 656            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)            402

TABLE 657            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            402

TABLE 658            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY TYPE,  2023–2030 (USD MILLION)      402

TABLE 659            NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)       403

TABLE 660            US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            404

TABLE 661            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            404

TABLE 662            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 404

TABLE 663            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)                 405

TABLE 664            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            405

TABLE 665            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 405

TABLE 666            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)                 406

TABLE 667            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            406

TABLE 668            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            406

TABLE 669            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)                 407

TABLE 670            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            407

TABLE 671            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,

BY TYPE, 2023–2030 (USD MILLION)         407

TABLE 672            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 673            US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            408

TABLE 674            US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            409

TABLE 675            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE,  2023–2030 (USD MILLION)            409

TABLE 676            US: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            409

TABLE 677            US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)                 410

TABLE 678            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            410

TABLE 679            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         411

TABLE 680            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            411

TABLE 681            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION)            411

TABLE 682            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            412

TABLE 683            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            412

TABLE 684            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY TYPE, 2023–2030 (USD MILLION)         412

TABLE 685            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 413

TABLE 686            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            413

TABLE 687            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         413

TABLE 688            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            414

TABLE 689            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 414

TABLE 690            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         414

TABLE 691            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            415

TABLE 692            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            415

TABLE 693            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         416

TABLE 694            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 416

TABLE 695            CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            416

TABLE 696            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      418

TABLE 697            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            419

TABLE 698            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            419

TABLE 699            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            419

TABLE 700            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         420

TABLE 701            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY TYPE, 2023–2030 (USD MILLION)         420

TABLE 702            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 420

TABLE 703            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         421

TABLE 704            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY TYPE, 2023–2030 (USD MILLION)         421

TABLE 705            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 421

TABLE 706            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE, 2023–2030 (USD MILLION)                 422

TABLE 707            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         422

TABLE 708            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE, 2023–2030 (USD MILLION)                 422

TABLE 709            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 423

TABLE 710            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION) 423

TABLE 711            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            424

TABLE 712            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            424

TABLE 713            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            425

TABLE 714            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 425

TABLE 715            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            425

TABLE 716            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            426

TABLE 717            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         427

TABLE 718            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            427

TABLE 719            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            427

TABLE 720            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            428

TABLE 721            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            428

TABLE 722            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            428

TABLE 723            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            429

TABLE 724            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            429

TABLE 725            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            429

TABLE 726            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            430

TABLE 727            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 430

TABLE 728            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         430

TABLE 729            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            431

TABLE 730            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            431

TABLE 731            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         432

TABLE 732            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)          432

TABLE 733            CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            432

TABLE 734            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            433

TABLE 735            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         434

TABLE 736            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            434

TABLE 737            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            434

TABLE 738            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            435

TABLE 739            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            435

TABLE 740            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            435

TABLE 741            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            436

TABLE 742            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            436

TABLE 743            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            436

TABLE 744            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            437

TABLE 745            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 437

TABLE 746            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         437

TABLE 747            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            438

TABLE 748            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            438

TABLE 749            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         439

TABLE 750            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            439

TABLE 751            JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            439

TABLE 752            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            441

TABLE 753            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         441

TABLE 754            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            441

TABLE 755            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            442

TABLE 756            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            442

TABLE 757            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            442

TABLE 758            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            443

TABLE 759            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,

2023–2030 (USD MILLION)            443

TABLE 760            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            443

TABLE 761            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            444

TABLE 762            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            444

TABLE 763            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,

BY TYPE, 2023–2030 (USD MILLION)         444

TABLE 764            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         445

TABLE 765            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            445

TABLE 766            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            446

TABLE 767            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         446

TABLE 768            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            446

TABLE 769            INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,  2023–2030 (USD MILLION)            447

TABLE 770            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            447

TABLE 771            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            448

TABLE 772            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         448

TABLE 773            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY TYPE, 2023–2030 (USD MILLION)         448

TABLE 774            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 449

TABLE 775            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         449

TABLE 776            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)            449

TABLE 777            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 450

TABLE 778            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)                 450

TABLE 779            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            450

TABLE 780            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,  2023–2030 (USD MILLION)                 451

TABLE 781            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 451

TABLE 782            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION) 451

TABLE 783            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)                 452

TABLE 784            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)                 452

TABLE 785            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            453

TABLE 786            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 453

TABLE 787            SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            453

TABLE 788            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,  2023–2030 (USD MILLION)                 454

TABLE 789            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            455

TABLE 790            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       455

TABLE 791            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION)       455

TABLE 792            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         456

TABLE 793            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,  BY TYPE, 2023–2030 (USD MILLION)       456

TABLE 794            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)       456

TABLE 795            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,  BY TYPE, 2023–2030 (USD MILLION) 457

TABLE 796            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH,

BY TYPE, 2023–2030 (USD MILLION)         457

TABLE 797            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       457

TABLE 798            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY TYPE, 2023–2030 (USD MILLION)         458

TABLE 799            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            458

TABLE 800            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            458

TABLE 801            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FUNCTIONALITY,  2023–2030 (USD MILLION)              459

TABLE 802            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)            459

TABLE 803            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION)            460

TABLE 804            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY TYPE,  2023–2030 (USD MILLION)      460

TABLE 805            REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)       460

TABLE 806            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      462

TABLE 807            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            462

TABLE 808            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            462

TABLE 809            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            463

TABLE 810            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       463

TABLE 811            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION)       463

TABLE 812            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION)            464

TABLE 813            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         464

TABLE 814            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY TYPE, 2023–2030 (USD MILLION)       464

TABLE 815            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY TYPE, 2023–2030 (USD MILLION)         465

TABLE 816            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)            465

TABLE 817            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       465

TABLE 818            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,  2023–2030 (USD MILLION)            466

TABLE 819            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            466

TABLE 820            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            466

TABLE 821            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)            467

TABLE 822            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)            467

TABLE 823            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            468

TABLE 824            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)            468

TABLE 825            LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)       468

TABLE 826            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            469

TABLE 827            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         469

TABLE 828            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            470

TABLE 829            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            470

TABLE 830            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            470

TABLE 831            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            471

TABLE 832            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            471

TABLE 833            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 471

TABLE 834            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            472

TABLE 835            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            472

TABLE 836            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            472

TABLE 837            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 473

TABLE 838            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         473

TABLE 839            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            474

TABLE 840            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            474

TABLE 841            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         475

TABLE 842            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            475

TABLE 843            BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            475

TABLE 844            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            476

TABLE 845            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         476

TABLE 846            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            477

TABLE 847            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            477

TABLE 848            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            477

TABLE 849            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            478

TABLE 850            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)            478

TABLE 851            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 478

TABLE 852            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            479

TABLE 853            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            479

TABLE 854            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            479

TABLE 855            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 480

TABLE 856            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         480

TABLE 857            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            481

TABLE 858            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            481

TABLE 859            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         482

TABLE 860            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            482

TABLE 861            MEXICO: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            482

TABLE 862            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,  2023–2030 (USD MILLION)                 483

TABLE 863            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            483

TABLE 864            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       484

TABLE 865            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION)       484

TABLE 866            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE, 2023–2030 (USD MILLION)            484

TABLE 867            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 485

TABLE 868            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)       485

TABLE 869            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,  BY TYPE, 2023–2030 (USD MILLION) 485

TABLE 870            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH,

BY TYPE, 2023–2030 (USD MILLION)         486

TABLE 871            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       486

TABLE 872            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,  BY TYPE, 2023–2030 (USD MILLION)            486

TABLE 873            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            487

TABLE 874            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            487

TABLE 875            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FUNCTIONALITY,  2023–2030 (USD MILLION)              488

TABLE 876            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FORMULATION,  2023–2030 (USD MILLION) 488

TABLE 877            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION)            489

TABLE 878            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,  BY TYPE, 2023–2030 (USD MILLION)            489

TABLE 879            REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)                 489

TABLE 880            MIDDLE EAST: KEY MACROECONOMIC INDICATORS      491

TABLE 881            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            491

TABLE 882            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            491

TABLE 883            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            492

TABLE 884            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         492

TABLE 885            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,

BY TYPE, 2023–2030 (USD MILLION)         492

TABLE 886            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)                 493

TABLE 887            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         493

TABLE 888            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,

BY TYPE, 2023–2030 (USD MILLION)         493

TABLE 889            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 494

TABLE 890            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)                 494

TABLE 891            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         494

TABLE 892            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,  2023–2030 (USD MILLION)                 495

TABLE 893            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION) 495

TABLE 894            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION) 495

TABLE 895            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)                 496

TABLE 896            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            496

TABLE 897            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            497

TABLE 898            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,  2023–2030 (USD MILLION)                 497

TABLE 899            MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            497

TABLE 900            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          498

TABLE 901            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)            498

TABLE 902            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       499

TABLE 903            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES,  BY TYPE, 2023–2030 (USD MILLION)       499

TABLE 904            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,  2023–2030 (USD MILLION)            499

TABLE 905            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE, 2023–2030 (USD MILLION) 500

TABLE 906            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS,  BY TYPE, 2023–2030 (USD MILLION)       500

TABLE 907            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE,

BY TYPE, 2023–2030 (USD MILLION)         500

TABLE 908            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,  2023–2030 (USD MILLION)            501

TABLE 909            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS,  BY TYPE, 2023–2030 (USD MILLION)       501

TABLE 910            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,  2023–2030 (USD MILLION)            501

TABLE 911            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            502

TABLE 912            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            502

TABLE 913            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,  2023–2030 (USD MILLION)            503

TABLE 914            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,  2023–2030 (USD MILLION)            503

TABLE 915            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,  BY TYPE, 2023–2030 (USD MILLION)            504

TABLE 916            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES,

BY TYPE,  2023–2030 (USD MILLION)      504

TABLE 917            GCC COUNTRIES: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)       504

TABLE 918            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,  2023–2030 (USD MILLION)                 505

TABLE 919            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            505

TABLE 920            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       506

TABLE 921            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE, 2023–2030 (USD MILLION)       506

TABLE 922            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS,

BY TYPE, 2023–2030 (USD MILLION)         506

TABLE 923            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS,  BY TYPE, 2023–2030 (USD MILLION)       507

TABLE 924            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE, 2023–2030 (USD MILLION)       507

TABLE 925            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE MARKET, BY TYPE, 2023–2030 (USD MILLION)       507

TABLE 926            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH,

BY TYPE, 2023–2030 (USD MILLION)         508

TABLE 927            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE, 2023–2030 (USD MILLION)       508

TABLE 928            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS,

BY TYPE, 2023–2030 (USD MILLION)         508

TABLE 929            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS, BY TYPE, 2023–2030 (USD MILLION)            509

TABLE 930            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2023–2030 (USD MILLION)            509

TABLE 931            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FUNCTIONALITY, 2023–2030 (USD MILLION) 510

TABLE 932            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FORMULATION, 2023–2030 (USD MILLION)    510

TABLE 933            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2023–2030 (USD MILLION)            511

TABLE 934            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE, 2023–2030 (USD MILLION)            511

TABLE 935            REST OF MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET,

BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)                 511

TABLE 936            AFRICA: KEY MACROECONOMIC INDICATORS                 513

TABLE 937            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            513

TABLE 938            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         513

TABLE 939            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OLEOCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            514

TABLE 940            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CARBOHYDRATES, BY TYPE,  2023–2030 (USD MILLION)            514

TABLE 941            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGARS, BY TYPE,

2023–2030 (USD MILLION)            514

TABLE 942            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ACTUAL SUGARS, BY TYPE,  2023–2030 (USD MILLION)            515

TABLE 943            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SUGAR ALCOHOLS, BY TYPE,  2023–2030 (USD MILLION)            515

TABLE 944            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CELLULOSE, BY TYPE,  2023–2030 (USD MILLION)                 515

TABLE 945            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STARCH, BY TYPE,

2023–2030 (USD MILLION)            516

TABLE 946            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PETROCHEMICALS, BY TYPE,  2023–2030 (USD MILLION)            516

TABLE 947            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR GLYCOLS, BY TYPE,

2023–2030 (USD MILLION)            516

TABLE 948            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MINERAL HYDROCARBONS,  BY TYPE, 2023–2030 (USD MILLION) 517

TABLE 949            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS,

BY TYPE, 2023–2030 (USD MILLION)         517

TABLE 950            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2023–2030 (USD MILLION)            518

TABLE 951            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2023–2030 (USD MILLION)            518

TABLE 952            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS,

BY TYPE, 2023–2030 (USD MILLION)         519

TABLE 953            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULES, BY TYPE,

2023–2030 (USD MILLION)            519

TABLE 954            AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2030 (USD MILLION)            519

TABLE 955            OVERVIEW OF MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2022–2024              520

TABLE 956            PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION         523

TABLE 957            PHARMACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT     529

TABLE 958            PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT FOOTPRINT 530

TABLE 959            PHARMACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT   531

TABLE 960            PHARMACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT     532

TABLE 961            PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES             535

TABLE 962            PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024                 536

TABLE 963            PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025        537

TABLE 964            PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2022–JUNE 2025              538

TABLE 965            PHARMACEUTICAL EXCIPIENTS MARKET: EXPANSIONS,

JANUARY 2022–JUNE 2025              539

TABLE 966            INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW        540

TABLE 967            INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED         541

TABLE 968            INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS,

JANUARY 2022–JUNE 2025              543

TABLE 969            INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS,

JANUARY 2022–JUNE 2025              543

TABLE 970            ADM: COMPANY OVERVIEW       545

TABLE 971            ADM: PRODUCTS OFFERED        546

TABLE 972            ADM: DEALS, JANUARY 2022–JUNE 2025  547

TABLE 973            ROQUETTE FRÈRES: COMPANY OVERVIEW                 548

TABLE 974            ROQUETTE FRÈRES: PRODUCTS OFFERED                 549

TABLE 975            ROQUETTE FRÈRES: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              554

TABLE 976            ROQUETTE FRÈRES: DEALS, JANUARY 2022–JUNE 2025             554

TABLE 977            BASF SE: COMPANY OVERVIEW 556

TABLE 978            BASF SE: PRODUCTS OFFERED  557

TABLE 979            BASF SE: DEALS, JANUARY 2022–JUNE 2025                 560

TABLE 980            BASF SE: EXPANSIONS, JANUARY 2022–JUNE 2025                 560

TABLE 981            EVONIK: COMPANY OVERVIEW 562

TABLE 982            EVONIK: PRODUCTS OFFERED 563

TABLE 983            EVONIK: EXPANSIONS, JANUARY 2022–JUNE 2025                 564

TABLE 984            ASHLAND: COMPANY OVERVIEW             566

TABLE 985            ASHLAND: PRODUCTS OFFERED              567

TABLE 986            ASHLAND: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025   569

TABLE 987            KERRY GROUP PLC: COMPANY OVERVIEW                 571

TABLE 988            KERRY GROUP PLC: PRODUCTS OFFERED                 572

TABLE 989            KERRY GROUP PLC: DEALS, JANUARY 2022–JUNE 2025        573

TABLE 990            MERCK: COMPANY OVERVIEW  574

TABLE 991            MERCK: PRODUCTS OFFERED   575

TABLE 992            MERCK: DEALS, JANUARY 2022–JUNE 2025                 577

TABLE 993            ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW          578

TABLE 994            ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED             579

TABLE 995            ASSOCIATED BRITISH FOODS PLC: DEALS, JANUARY 2022–JUNE 2025              581

TABLE 996            WACKER CHEMIE AG: COMPANY OVERVIEW                 582

TABLE 997            WACKER CHEMIE AG: PRODUCTS OFFERED                 583

TABLE 998            AIR LIQUIDE: COMPANY OVERVIEW       584

TABLE 999            AIR LIQUIDE: PRODUCTS OFFERED        585

TABLE 1000         AIR LIQUIDE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025   587

TABLE 1001         DOW: COMPANY OVERVIEW      588

TABLE 1002         DOW: PRODUCTS OFFERED       589

TABLE 1003         BERKSHIRE HATHAWAY: COMPANY OVERVIEW                 590

TABLE 1004         BERKSHIRE HATHAWAY: PRODUCTS OFFERED                 591

TABLE 1005         BERKSHIRE HATHAWAY: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              592

TABLE 1006         COLORCON, INC.: COMPANY OVERVIEW                 593

TABLE 1007         COLORCON, INC.: PRODUCTS OFFERED                 593

TABLE 1008         COLORCON, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              594

TABLE 1009         COLORCON, INC.: DEALS, JANUARY 2022–JUNE 2025        594

TABLE 1010         COLORCON, INC.: EXPANSIONS, JANUARY 2022–JUNE 2025             595

TABLE 1011         DFE PHARMA: COMPANY OVERVIEW     596

TABLE 1012         DFE PHARMA: PRODUCTS OFFERED      596

TABLE 1013         DFE PHARMA: DEALS, JANUARY 2022–JUNE 2025                 598

TABLE 1014         ACTYLIS: COMPANY OVERVIEW                599

TABLE 1015         ACTYLIS: PRODUCTS OFFERED 599

TABLE 1016         ACTYLIS: DEALS, JANUARY 2022–JUNE 2025                 604

TABLE 1017         CRODA INTERNATIONAL PLC: COMPANY OVERVIEW          605

TABLE 1018         CRODA INTERNATIONAL PLC: PRODUCTS OFFERED             606

TABLE 1019         CRODA INTERNATIONAL PLC: DEALS, JANUARY 2022–JUNE 2025  607

TABLE 1020         CRODA INTERNATIONAL PLC: EXPANSIONS, JANUARY 2022–JUNE 2025              607

TABLE 1021         CHEMIE TRADE: COMPANY OVERVIEW 608

TABLE 1022         CHEMIE TRADE: PRODUCTS OFFERED  608

TABLE 1023         GATTEFOSSÉ: COMPANY OVERVIEW      609

TABLE 1024         GATTEFOSSÉ: PRODUCTS OFFERED       609

TABLE 1025         J. RETTENMAIER & SÖHNE GMBH + CO KG: COMPANY OVERVIEW   611

TABLE 1026         J. RETTENMAIER & SÖHNE GMBH + CO KG: PRODUCTS OFFERED    611

TABLE 1027         SHIN-ETSU CHEMICAL CO., LTD.: COMPANY OVERVIEW          613

TABLE 1028         SHIN-ETSU CHEMICAL CO., LTD.: PRODUCTS OFFERED             614

TABLE 1029         SHIN-ETSU CHEMICAL CO., LTD.: DEALS, JANUARY 2022–JUNE 2025              615

TABLE 1030         SHIN-ETSU CHEMICAL CO., LTD.: EXPANSIONS, JANUARY 2022–JUNE 2025              615

TABLE 1031         INNOPHOS: COMPANY OVERVIEW          616

TABLE 1032         MEGGLE GMBH & CO. KG: COMPANY OVERVIEW          617

TABLE 1033         FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW   618

TABLE 1034         COREL PHARMA CHEM: COMPANY OVERVIEW                 618

TABLE 1035         BIOGRUND: COMPANY OVERVIEW          619

TABLE 1036         NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.: COMPANY OVERVIEW       620

TABLE 1037         R.T. VANDERBILT HOLDING COMPANY, INC.: COMPANY OVERVIEW   621

TABLE 1038         BENEO: COMPANY OVERVIEW  622

TABLE 1039         SIAGACHI INDUSTRIES: COMPANY OVERVIEW                 623

TABLE 1040         JH NANHANG LIFE SCIENCES CO., LTD.: COMPANY OVERVIEW   624

LIST OF FIGURES

FIGURE 1              PHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION              62

FIGURE 2              PHARMACEUTICAL EXCIPIENTS REGIONAL SCOPE  63

FIGURE 3              PHARMACEUTICAL EXCIPIENTS MARKET: YEARS CONSIDERED      64

FIGURE 4              PHARMACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN         66

FIGURE 5              PHARMACEUTICAL EXCIPIENTS MARKET: KEY DATA FROM SECONDARY SOURCES        68

FIGURE 6              PHARMACEUTICAL EXCIPIENTS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS               69

FIGURE 7              PHARMACEUTICAL EXCIPIENTS MARKET ESTIMATION

(SUPPLY-SIDE ANALYSIS), 2024  70

FIGURE 8              COMPANY REVENUE ANALYSIS-BASED ESTIMATION: BOTTOM-UP APPROACH, 2024      71

FIGURE 9              REVENUE SHARE ANALYSIS OF SANDOZ GROUP AG, 2024                71

FIGURE 10            PHARMACEUTICAL EXCIPIENTS MARKET SIZE VALIDATION FROM PRIMARY SOURCES                73

FIGURE 11            PHARMACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH          74

FIGURE 12            PHARMACEUTICAL EXCIPIENTS MARKET: CAGR PROJECTIONS   75

FIGURE 13            PHARMACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION                77

FIGURE 14            PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      80

FIGURE 15            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY,

2025 VS. 2030 (USD MILLION)      81

FIGURE 16            PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION,

2025 VS. 2030 (USD MILLION)      82

FIGURE 17            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION,

2025 VS. 2030 (USD MILLION)      82

FIGURE 18            GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL EXCIPIENTS MARKET             83

FIGURE 19            GROWING DEMAND FOR GENERICS AND PHARMACEUTICAL PRODUCTS TO DRIVE MARKET        84

FIGURE 20            ORGANIC CHEMICALS SEGMENT AND US TO LEAD NORTH AMERICAN MARKET

IN 2025  85

FIGURE 21            GERMANY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       86

FIGURE 22            EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD  86

FIGURE 23            PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 87

FIGURE 24            GLOBAL PHARMACEUTICAL R&D SPEND, 2018–2028        90

FIGURE 25            REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENT PROVIDERS        98

FIGURE 26            INDICATIVE PRICING ANALYSIS EXCIPIENT PRODUCTS, 2024               100

FIGURE 27            INDICATIVE PRICING ANALYSIS OF EXCIPIENT PRODUCTS, BY REGION, 2024     101

FIGURE 28            PHARMACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS               102

FIGURE 29            PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS             103

FIGURE 30            PHARMACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM ANALYSIS  104

FIGURE 31            PHARMACEUTICAL EXCIPIENTS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022–2024          106

FIGURE 32            PHARMACEUTICAL EXCIPIENTS MARKET: PATENT ANALYSIS,

JANUARY 2014–DECEMBER 2024 108

FIGURE 33            PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS           131

FIGURE 34            INFLUENCE OF KEY STAKEHOLDERS IN BUYING PROCESS, BY PRODUCT                132

FIGURE 35            KEY BUYING CRITERIA, BY END USER    133

FIGURE 36            PHARMACEUTICAL EXCIPIENTS MARKET: AI USE CASES           135

FIGURE 37            EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT       345

FIGURE 38            ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT       418

FIGURE 39            REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD MILLION) 522

FIGURE 40            MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL EXCIPIENTS MARKET, 2024  523

FIGURE 41            EV/EBITDA OF KEY VENDORS   524

FIGURE 42            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  525

FIGURE 43            PHARMACEUTICAL EXCIPIENTS MARKET: BRAND/PRODUCT COMPARISON             525

FIGURE 44            PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       527

FIGURE 45            PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT 528

FIGURE 46            PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 534

FIGURE 47            INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT (2024)            541

FIGURE 48            ADM: COMPANY SNAPSHOT (2024)          546

FIGURE 49            ROQUETTE FRÈRES: COMPANY SNAPSHOT (2024)    549

FIGURE 50            BASF SE: COMPANY SNAPSHOT (2024)    557

FIGURE 51            EVONIK: COMPANY SNAPSHOT (2024)   563

FIGURE 52            ASHLAND: COMPANY SNAPSHOT (2024)                 567

FIGURE 53            KERRY GROUP PLC: COMPANY SNAPSHOT (2024)    572

FIGURE 54            MERCK: COMPANY SNAPSHOT (2024)     575

FIGURE 55            ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2024)             579

FIGURE 56            WACKER CHEMIE AG: COMPANY SNAPSHOT (2024)    583

FIGURE 57            AIR LIQUIDE: COMPANY SNAPSHOT (2024)                 585

FIGURE 58            DOW: COMPANY SNAPSHOT (2024)         589

FIGURE 59            BERKSHIRE HATHAWAY: COMPANY SNAPSHOT (2024)    590

FIGURE 60            CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT (2024)             606

FIGURE 61            SHIN-ETSU CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2024)             614

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧